Browsing by Author González Suárez, Eva
Showing results 17 to 26 of 26
< previous
Issue Date | Title | Author(s) |
---|---|---|
1-Dec-2016 | Patient-derived xenograft (PDX) models in basic and translational breast cancer research | Dobrolecki, Lacey E.; Airhart, Susie D.; Alférez, Denis G.; Aparicio, Samuel; Behbod, Fariba; Bentires-Alj, Mohamed; Brisken, Cathrin; Bult, Carol J.; Cai, Shirong; Clarke, Robert B.; Dowst, Heidi; Ellis, Matthew J.; González Suárez, Eva; Iggo, Richard D.; Kabos, Peter; Li, Shunqiang; Lindeman, Geoffrey J.; Marangoni, Elisabetta; McCoy, Aaron; Meric-Bernstam, Funda; Piwnica-Worms, Helena; Poupon, Marie-France; Reis-Filho, Jorge; Sartorius, Carol A.; Scabia, Valentina; Sflomos, George; Tu, Yizheng; Vaillant, François; Visvader, Jane E.; Welm, Alana; Wicha, Max S.; Lewis, Michael T. |
18-Feb-2023 | Rank ectopic expression in the presence of Neu and PyMT oncogenes alters mammary epithelial cell populations and their tumorigenic potential | Cordero, Alex; Santamaría, Patricia G.; González Suárez, Eva |
1-Jan-2021 | RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness | Benítez, Sandra; Cordero, Alex; Santamaría, Patricia G.; Redondo Pedraza, Jaime; Rocha, Ana S.; Collado-Solé, Alejandro; Jimenez, Maria; Sanz Moreno, Adrian; Yoldi, Guillermo; Santos, Juliana C.; Benedictis, Ilaria De; Gómez Aleza, Clara; Silva Álvarez, Sabela Da; Troulé, Kevin; Gómez López, Gonzalo; Alcazar, Noelia; Palmero, Ignacio; Collado, Manuel; Serrano Marugán, Manuel; González Suárez, Eva |
23-Oct-2018 | RANK signaling in mammary spontaneous tumorigenesis and tumor-stromal crosstalk | Yoldi, Guillermo |
30-Mar-2021 | RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer | Sanz Moreno, Adrián; Palomeras, Sonia; Pedersen, Kim; Morancho, Beatriz; Pascual, Tomás; Galván, Patricia; Benítez, Sandra; Gómez Miragaya, Jorge; Ciscar, Marina; Jimenez, Maria; Pernas, Sònia; Petit, Anna; Soler, María Teresa; Viñas, Gemma; Alsaleem, Mansour; Rakha, Emad A.; Green, Andrew R.; Santamaria, Patricia G.; Mulder, Celine; Lemeer, Simone; Arribas, Joaquín V. (Vicente); Prat Aparicio, Aleix; Puig, Teresa; González Suárez, Eva |
3-Oct-2022 | RANK-RANKL signaling in breast cancer. Therapeutic applications of RANKL inhibition in breast cancer | Ciscar García, Marina |
1-Dec-2016 | RANKL inhibitors for osteosarcoma treatment: hope and caution | Trinidad Alvarez, Eva Maria; González Suárez, Eva |
May-2017 | Resistance to taxanes in triple negative breast cancer associates with the dynamics of a CD49f+ tumor initiating population | Gómez Miragaya, Jorge; Palafox Sánchez, Marta; Paré, Laia; Yoldi, Guillermo; Ferrer, Irene; Vila, Sergi; Galván, Patricia; Pellegrini, Pasquale; Pérez-Montoyo, Hector; Igea, Ana; Muñoz Moruno, Purificación; Esteller, Manel; Nebreda, Àngel R.; Urruticoechea Ribate, Ander; Morilla, Idoia; Pernas, Sònia; Climent, Fina; Soler, María Teresa; Petit, Anna; Serra, Violeta; Prat Aparicio, Aleix; González Suárez, Eva |
1-Oct-2019 | The altered transcriptome and DNA methylation profiles of docetaxel resistance in breast cancer PDX models | Gómez Miragaya, Jorge; Moran, Sebastian; Calleja Cervantes, Maria E.; Collado-Solé, Alejandro; Paré, Laia; Gómez, Antonio; Serra, Violeta; Dobrolecki, Lacey E.; Lewis, Michael T.; Diaz-Lagares, Angel; Eroles, Pilar; Prat Aparicio, Aleix; Esteller, Manel; González Suárez, Eva |
25-Oct-2021 | The role of RANK pathway in the intestinal epithelium, breast cancer and tumor immune modulation | Gómez Aleza, Clara |